Long‐term outcomes after cytoreductive partial nephrectomy for metastatic renal cell carcinoma
Fuente:
Wiley Open Access
Saved in:
| Main Authors: | Andrea Lopez Sanmiguel, Yash S. Khandwala, Emily A. Vertosick, Daniel Barbakoff, Roya Ghavamian, Jonathan A. Coleman, Mark Dawidek, Andrew J. Vickers, A. Ari Hakimi, Paul Russo |
|---|---|
| Format: | Artículo Open Access |
| Published: |
Wiley
2026
|
| Subjects: | |
| Online Access: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
Utilization of cardiopulmonary bypass at radical nephrectomy for renal cell carcinoma with tumour thrombus
by: Chalairat Suk‐Ouichai, et al.
Published: (2024)
by: Chalairat Suk‐Ouichai, et al.
Published: (2024)
Recurrence patterns following nephrectomy for renal cell carcinoma in a Danish nationwide cohort
by: Goran Bencina, et al.
Published: (2024)
by: Goran Bencina, et al.
Published: (2024)
Impact of Mayo Adhesive Probability score and BMI on renal functional decline after robotic assisted partial nephrectomy
by: Cesare Saitta, et al.
Published: (2024)
by: Cesare Saitta, et al.
Published: (2024)
Efficacy of immune checkpoint inhibitor combination therapy prior to nephrectomy in advanced renal cell carcinoma: A retrospective pilot study
by: Sho Kiyota, et al.
Published: (2024)
by: Sho Kiyota, et al.
Published: (2024)
Cinematic rendering of 18 F‐DCFPyL PET/CT fusion data in a patient with metastatic clear cell renal cell carcinoma
by: Steven P. Rowe, et al.
Published: (2024)
by: Steven P. Rowe, et al.
Published: (2024)
Accuracy of warm ischemia time measurement using a surgical intelligence software in partial nephrectomies: A validation study
by: Archan Khandekar, et al.
Published: (2024)
by: Archan Khandekar, et al.
Published: (2024)
Clinical trial protocol of PODRACING: A randomized controlled trial evaluating 3D perfusion zone models for selective arterial clamping during robot‐assisted partial nephrectomy
by: Joris Vangeneugden, et al.
Published: (2026)
by: Joris Vangeneugden, et al.
Published: (2026)
Does the transfer of knowledge from the pioneer generation to the second‐generation speed‐up the learning curve of robot‐assisted partial nephrectomies? TRANSFER trial (UroCCR n°83)
by: Louis Vignot, et al.
Published: (2024)
by: Louis Vignot, et al.
Published: (2024)
Penile trauma management in absence of fracture: Long‐term outcomes
by: Kalpesh Parmar, et al.
Published: (2025)
by: Kalpesh Parmar, et al.
Published: (2025)
Neoadjuvant tislelizumab plus pazopanib in renal cell carcinoma with venous tumour thrombus: A retrospective study
by: Diliyaer Dilixiati, et al.
Published: (2025)
by: Diliyaer Dilixiati, et al.
Published: (2025)
Robotic‐assisted approaches to urachal carcinoma: A comprehensive systematic review of the safety and efficacy outcomes
by: Caio Vinícius Suartz, et al.
Published: (2024)
by: Caio Vinícius Suartz, et al.
Published: (2024)
Long‐term outcomes of cutaneous ureterostomy with the aim of stent‐free stoma
by: Chul Jang Kim, et al.
Published: (2025)
by: Chul Jang Kim, et al.
Published: (2025)
Machine learning analysis for detecting late recurrence and loss to follow‐up after renal cell carcinoma surgery
by: Kodai Sato, et al.
Published: (2024)
by: Kodai Sato, et al.
Published: (2024)
Peak early‐phase enhancement ratio on contrast‐enhanced MRI to differentiate chromophobe renal cell carcinoma from oncocytoma
by: Deanna Thorson, et al.
Published: (2025)
by: Deanna Thorson, et al.
Published: (2025)
Long‐term intermittent catheterization: Safety and outcomes from a prospective observational study
by: Peter Taffo, et al.
Published: (2026)
by: Peter Taffo, et al.
Published: (2026)
Flexible cystoscopy‐guided implantation of ProACT: Surgical technique and long‐term outcomes
by: Dimitri Paillusson, et al.
Published: (2025)
by: Dimitri Paillusson, et al.
Published: (2025)
Video‐endoscopic versus open inguinal lymphadenectomy: Long‐term oncological outcomes in penile cancer
by: Ranya Kumar, et al.
Published: (2026)
by: Ranya Kumar, et al.
Published: (2026)
Competing risk of death in patients with low, intermediate and high risk of recurrence after radical surgery for clear cell renal cell carcinoma
by: Anna Brännbäck, et al.
Published: (2025)
by: Anna Brännbäck, et al.
Published: (2025)
Endoscopic management of ureteral injuries arising from gynecologic procedures
by: Ari Luder, et al.
Published: (2026)
by: Ari Luder, et al.
Published: (2026)
Primary urethral cancer: Treatment patterns, responses and survival in localized, advanced and metastatic patients
by: Ilfad Blazevic, et al.
Published: (2025)
by: Ilfad Blazevic, et al.
Published: (2025)
Urinary microbiota diversity and composition in patients with advanced renal cell cancer
by: Frederico Leal, et al.
Published: (2026)
by: Frederico Leal, et al.
Published: (2026)
Extended versus limited pelvic lymph node dissection and long‐term outcomes in high‐risk prostate cancer before radiotherapy
by: Georgios Daouacher, et al.
Published: (2026)
by: Georgios Daouacher, et al.
Published: (2026)
Long‐term outcome of transurethral laser ablation for recurrent non‐muscle invasive bladder cancer: An EORTC risk‐matched study
by: Chase Peng Yun Ng, et al.
Published: (2025)
by: Chase Peng Yun Ng, et al.
Published: (2025)
Comparing GreenLight PVP and HoLEP beyond 5 years: A systematic review of long‐term functional outcomes and reoperation rates
by: Arthur Yim, et al.
Published: (2025)
by: Arthur Yim, et al.
Published: (2025)
PARP inhibitor‐based treatment in metastatic, castration‐resistant prostate cancer (mCRPC): A systematic review and meta‐analysis
by: Michela Roberto, et al.
Published: (2025)
by: Michela Roberto, et al.
Published: (2025)
The impact of pre‐biopsy MRI and additional testing on prostate cancer screening outcomes: A rapid review
by: Abel Tesfai, et al.
Published: (2024)
by: Abel Tesfai, et al.
Published: (2024)
The potential role of precision medicine to alleviate racial disparities in prostate, bladder and renal urological cancer care
by: Kunal K. Sindhu, et al.
Published: (2024)
by: Kunal K. Sindhu, et al.
Published: (2024)
Understanding the long‐term impact of the COVID‐19 pandemic on non‐muscle‐invasive bladder cancer outcomes: 12‐Month follow‐up data from the international, prospective COVIDSurg Cancer study
by: Cameron E. Alexander, et al.
Published: (2024)
by: Cameron E. Alexander, et al.
Published: (2024)
Predictive role of ABC transporters in the efficacy of enfortumab vedotin for urothelial carcinoma
by: Toshiki Kijima, et al.
Published: (2025)
by: Toshiki Kijima, et al.
Published: (2025)
Assessing EAU criteria for high‐risk upper tract urothelial carcinoma
by: Mahmoud Farzat, et al.
Published: (2025)
by: Mahmoud Farzat, et al.
Published: (2025)
Hospital variation in the treatment of cT1a renal cancer
by: Cato Caroline Bresser, et al.
Published: (2026)
by: Cato Caroline Bresser, et al.
Published: (2026)
Questionable role of opioids for analgesia in renal colic and its urological interventions
by: Anna Krieger, et al.
Published: (2025)
by: Anna Krieger, et al.
Published: (2025)
Reduced p63 expression is linked to unfavourable prognosis in muscle‐invasive urothelial carcinoma of the bladder
by: Kira Furlano, et al.
Published: (2024)
by: Kira Furlano, et al.
Published: (2024)
Prognostic factors and treatment impact on overall survival in patients with renal neuroendocrine tumour
by: Olamide O. Omidele, et al.
Published: (2024)
by: Olamide O. Omidele, et al.
Published: (2024)
Racial and socioeconomic disparities from time of diagnosis to treatment for small renal masses
by: Lila G. McGrath, et al.
Published: (2026)
by: Lila G. McGrath, et al.
Published: (2026)
A modified Delphi consensus statement on the role of biopsy in small renal masses
by: Darryl E. Bernstein, et al.
Published: (2025)
by: Darryl E. Bernstein, et al.
Published: (2025)
Understanding symptom contribution to sex inequality in bladder and renal cancer stage at diagnosis
by: Yin Zhou, et al.
Published: (2024)
by: Yin Zhou, et al.
Published: (2024)
Cumulative incidence and risk factors for recurrence of upper tract urothelial carcinoma in patients undergoing radical cystectomy
by: Ryo Yamashita, et al.
Published: (2024)
by: Ryo Yamashita, et al.
Published: (2024)
Waiting time in diagnosis and extirpative surgery and association with survival and stage progression in upper tract urothelial carcinomas
by: Fredrik Liedberg, et al.
Published: (2025)
by: Fredrik Liedberg, et al.
Published: (2025)
Risk factors for readmission after ureteroscopy for stone disease: Modern single centre experience
by: Shuhei Hirano, et al.
Published: (2025)
by: Shuhei Hirano, et al.
Published: (2025)
Similar Items
-
Utilization of cardiopulmonary bypass at radical nephrectomy for renal cell carcinoma with tumour thrombus
by: Chalairat Suk‐Ouichai, et al.
Published: (2024) -
Recurrence patterns following nephrectomy for renal cell carcinoma in a Danish nationwide cohort
by: Goran Bencina, et al.
Published: (2024) -
Impact of Mayo Adhesive Probability score and BMI on renal functional decline after robotic assisted partial nephrectomy
by: Cesare Saitta, et al.
Published: (2024) -
Efficacy of immune checkpoint inhibitor combination therapy prior to nephrectomy in advanced renal cell carcinoma: A retrospective pilot study
by: Sho Kiyota, et al.
Published: (2024) -
Cinematic rendering of 18 F‐DCFPyL PET/CT fusion data in a patient with metastatic clear cell renal cell carcinoma
by: Steven P. Rowe, et al.
Published: (2024)